Literature DB >> 15510242

Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease.

Changiz Geula1, Sultan Darvesh.   

Abstract

Butyrylcholinesterase is a serine hydrolase biochemically related to the cholinergic enzyme acetylcholinesterase. It is capable of hydrolyzing esters of choline. Butyrylcholinesterase has unique enzymatic properties and is widely distributed in the nervous system, raising the possibility of its involvement in neural function. In particular, recent evidence indicates that along with acetylcholinesterase, butyrylcholinesterase catalyzes the hydrolysis of acetylcholine, and thus serves as a co-regulator of cholinergic transmission. Accumulating evidence also indicates that butyrylcholinesterase is likely to be involved in neurodegenerative disorders such as Alzheimer's disease. Therefore, inhibition of butyrylcholinesterase will not only lead to enhanced cholinergic transmission but also has the potential to interfere with the disease process in Alzheimer's disease and other dementing disorders. 2004 Prous Science.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15510242     DOI: 10.1358/dot.2004.40.8.850473

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  15 in total

1.  Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.

Authors:  Katsuyoshi Mizukami; Hiroyasu Akatsu; Eric E Abrahamson; Zhiping Mi; Milos D Ikonomovic
Journal:  Neuropathology       Date:  2015-08-21       Impact factor: 1.906

2.  Scutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.

Authors:  Li-li Guo; Zhi-zhong Guan; Yong-lin Wang
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

Review 3.  Structure activity relationship of synaptic and junctional neurotransmission.

Authors:  Raj K Goyal; Arun Chaudhury
Journal:  Auton Neurosci       Date:  2013-03-25       Impact factor: 3.145

Review 4.  Cellular and molecular actions of Methylene Blue in the nervous system.

Authors:  Murat Oz; Dietrich E Lorke; Mohammed Hasan; George A Petroianu
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

5.  Effect of hypoxanthine, antioxidants and allopurinol on cholinesterase activities in rats.

Authors:  Morgahna Nathalie Wamser; Eduardo Fernandes Leite; Vinícius Vialle Ferreira; Daniela Delwing-de Lima; José Geraldo Pereira da Cruz; Angela T S Wyse; Débora Delwing-Dal Magro
Journal:  J Neural Transm (Vienna)       Date:  2013-02-12       Impact factor: 3.575

6.  Supplementation with vitamins E plus C or soy isoflavones in ovariectomized rats: effect on the activities of Na(+), K (+)-ATPase and cholinesterases.

Authors:  Siomara C Monteiro; Cristiane B Mattos; Emilene B S Scherer; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2007-05-19       Impact factor: 3.584

7.  The relation of high fat diet, metabolic disturbances and brain oxidative dysfunction: modulation by hydroxy citric acid.

Authors:  Kamal A Amin; Hamdy H Kamel; Mohamed A Abd Eltawab
Journal:  Lipids Health Dis       Date:  2011-05-14       Impact factor: 3.876

8.  Kinetics and Molecular Docking Studies of 6-Formyl Umbelliferone Isolated from Angelica decursiva as an Inhibitor of Cholinesterase and BACE1.

Authors:  Md Yousof Ali; Su Hui Seong; Machireddy Rajeshkumar Reddy; Sung Yong Seo; Jae Sue Choi; Hyun Ah Jung
Journal:  Molecules       Date:  2017-09-24       Impact factor: 4.411

9.  Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2.

Authors:  Regina Messerer; Clelia Dallanoce; Carlo Matera; Sarah Wehle; Lisa Flammini; Brian Chirinda; Andreas Bock; Matthias Irmen; Christian Tränkle; Elisabetta Barocelli; Michael Decker; Christoph Sotriffer; Marco De Amici; Ulrike Holzgrabe
Journal:  Medchemcomm       Date:  2017-04-27       Impact factor: 3.597

10.  Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation.

Authors:  Linn Malmsten; Swetha Vijayaraghavan; Outi Hovatta; Amelia Marutle; Taher Darreh-Shori
Journal:  J Cell Mol Med       Date:  2014-08-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.